| Presence of five chemotherapeutic drugs in breast milk as a guide for the safe use of chemotherapy during breastfeeding: results from a case series D Damoiseaux, S Calpe, H Rosing, JH Beijnen, ADR Huitema, C Lok, ... Clinical Pharmacology & Therapeutics 112 (2), 404-410, 2022 | 15 | 2022 |
| A phase 1 dose‐escalation study of low‐dose metronomic treatment with novel Oral paclitaxel formulations in combination with ritonavir in patients with advanced solid tumors VA de Weger, MAC Vermunt, FE Stuurman, AM Burylo, D Damoiseaux, ... Clinical Pharmacology in Drug Development 10 (6), 607-621, 2021 | 7 | 2021 |
| Predictiveness of the human-CYP3A4-transgenic mouse model (Cyp3aXAV) for human drug exposure of CYP3A4-metabolized drugs D Damoiseaux, W Li, A Martínez-Chávez, JH Beijnen, AH Schinkel, ... Pharmaceuticals 15 (7), 860, 2022 | 4 | 2022 |
| Predicting chemotherapy distribution into breast Milk for breastfeeding women using a population pharmacokinetic approach D Damoiseaux, D Centanni, JH Beijnen, F Amant, ADR Huitema, ... Clinical Pharmacokinetics 62 (7), 969-980, 2023 | 2 | 2023 |
| Population pharmacokinetic modelling to support the evaluation of preclinical pharmacokinetic experiments with lorlatinib D Damoiseaux, W Li, JH Beijnen, AH Schinkel, ADR Huitema, TPC Dorlo Journal of Pharmaceutical Sciences 111 (2), 495-504, 2022 | 2 | 2022 |
| Abstract B137: preclinical evaluation of a Wilms’ tumor protein 1-targeted interleukin-15 dendritic cell vaccine: T-cell activity and batch production M Versteven, D Damoiseaux, D Campillo-Davo, HV Acker, HD Reu, ... Cancer Immunology Research 7 (2_Supplement), B137-B137, 2019 | 2 | 2019 |
| Inter-and Intraspecies extrapolation for the exploration of the pharmacokinetics in untapped populations D Damoiseaux Utrecht University, 2024 | | 2024 |
| Predictability of human exposure by human‐CYP3A4‐transgenic mouse models: A meta‐analysis D Damoiseaux, AH Schinkel, JH Beijnen, ADR Huitema, TPC Dorlo Clinical and Translational Science 17 (1), e13668, 2024 | | 2024 |
| Physiologically‐based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milk D Damoiseaux, F Amant, JH Beijnen, S Barnett, GJ Veal, ADR Huitema, ... CPT: pharmacometrics & systems pharmacology 12 (12), 1931-1944, 2023 | | 2023 |
| High Accumulation of Nivolumab in Human Breast Milk: A Case Report D Damoiseaux, K de Jong, D Pluim, H Rosing, JH Beijnen, H van Thienen, ... Inter-and Intraspecies Extrapolation 166, 149, 2023 | | 2023 |
| High accumulation of nivolumab in human breast milk: A case report K de Jong, D Damoiseaux, D Pluim, H Rosing, JH Beijnen, H van Thienen, ... Biomedicine & Pharmacotherapy 166, 115354, 2023 | | 2023 |
| Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic Drugs JM Janssen, D Damoiseaux, JGC van Hasselt, FCH Amant, ... Clinical Pharmacokinetics 62 (8), 1157-1167, 2023 | | 2023 |
| Early Prediction and Impact Assessment of CYP3A4-Related Drug-Drug Interactions for Small Molecule Anti-cancer Drugs using Human-CYP3A4-transgenic Mouse Models D Damoiseaux, W Li, A Martínez-Chávez, JH Beijnen, AH Schinkel, ... Inter-and Intraspecies Extrapolation, 95, 0 | | |
